FDA Approves Treatment for Chronic Kidney Disease
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney function decline, kidney failure, cardiovascular death and hospitalization for heart …
Read More